Concepedia

Jasgit C. Sachdev

JC

Statistics

Publications

61

Citations

8.1K

H-Index

28

Active since

2009

Affiliations

HonorHealth(Current)

The University of Texas MD Anderson Cancer Center

Sarah Cannon

Translational Genomics Research Institute

Dana-Farber Cancer Institute

Jasgit C. Sachdev is an author at HonorHealth specializing in oncology, medicine, and pharmacology.

ORCID

Publications per year

2009–2023

61

Publications

61

Hepatobiliary Cancers

Al B. Benson, Thomas A. Abrams, Edgar Ben‐Josef et al. · Journal of the National Comprehensive Cancer Network · 2009 · 2.3K citations · Full text

, , +14

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

David S. Hong, Yoon‐Koo Kang, Mitesh J. Borad et al. · British Journal of Cancer · 2020 · 912 citations · Full text

, , +13

Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors

Muhammad S. Beg, Andrew Brenner, Jasgit C. Sachdev et al. · Investigational New Drugs · 2016 · 884 citations · Full text

, , +8

Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma

Panagiotis A. Konstantinopoulos, Steven Waggoner, Gregory A. Vidal et al. · JAMA Oncology · 2019 · 560 citations · Full text

, , +17

Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

Hope S. Rugo, Jean‐Pierre Delord, Seock‐Ah Im et al. · Clinical Cancer Research · 2018 · 387 citations

, , +17

1–5 of 61